Molecular Diagnostic and Precision Medicine in Non-Small Cell Lung Cancer. An Update on the Treatment of the Most Important Actionable Oncogenic Driver Alterations by David König, Sacha I. Rothschild

Get full text

Contributing to a value-based health care framework for lung cancer patients in Switzerland - A methodological approach to merge routinely collected hospital data. by Michaela Carla Barbier, Katya Galactionova, Mark Lambiris, Leonel Oliveira, Florian Rüter, Dominik Glinz, Jessica Thürmer, Flurina Pletscher, Benjamin Kasenda, Tobias Finazzi, David König, Didier Lardinois, Larissa Conrad, Leonie Mutz, Matthias Schwenkglenks

Get full text

Contributing to a value-based health care framework for lung cancer patients in Switzerland – A methodological approach to merge routinely collected hospital data by Michaela Carla Barbier, Katya Galactionova, Mark Lambiris, Leonel Oliveira, Florian Rüter, Dominik Glinz, Jessica Thürmer, Flurina Pletscher, Benjamin Kasenda, Tobias Finazzi, David König, Didier Lardinois, Larissa Conrad, Leonie Mutz, Matthias Schwenkglenks

Get full text

Outcomes in Patients With Resectable Stage III NSCLC Who Did Not Have Definitive Surgery After Neoadjuvant Treatment—A Retrospective Analysis of the SAKK Trials 16/96, 16/00, 16/01... by Sabine Raimann, MD, Sämi Schär, PhD, Stefanie Hayoz, PhD, Matthias Guckenberger, MD, Tobias Finazzi, MD, PhD, Isabelle Opitz, MD, Sabine Schmid, MD, Michael Mark, MD, Alfredo Addeo, MD, Laetitia A. Mauti, MD, PhD, Daniel C. Betticher, MD, Hans-Beat Ris, MD, Roger Stupp, MD, Alessandra Curioni-Fontecedro, MD, Solange Peters, MD, PhD, Martin Früh, MD, Sacha I. Rothschild, MD, PhD, Miklos Pless, MD, David König, MD

Get full text